Telmisartan/amlodipine
| Combination of | |
|---|---|
Angiotensin II receptor antagonist | |
| Amlodipine | Calcium channel blocker |
| Clinical data | |
| Trade names | Twynsta, others |
| License data | |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| KEGG | |
Telmisartan/amlodipine, sold under the brand name Twynsta among others, is a
angiotensin II receptor antagonist, and amlodipine, as the besilate, a calcium channel blocker.[2] It is taken by mouth.[2]
Common side effects include dizziness, swelling, and back pain.heart muscle.[2]
The combination was approved for medical use in the United States in 2009.generic medication.[6]
References
- ^ "Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017". Therapeutic Goods Administration (TGA). 21 June 2022. Retrieved 30 March 2024.
- ^ a b c d e f g h i "DailyMed - Telmisartan and Amlodipine tablet". DailyMed. Retrieved 30 October 2019.
- ^ "Twynsta (telmisartan/amlodipine) tablets, for oral use Initial U.S. Approval: 2009". DailyMed. Retrieved 18 March 2023.
- hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
- ^ "Telmisartan and Amlodipine (Professional Patient Advice)". Drugs.com. Retrieved 30 October 2019.
